Skip to content
Early concept sketches and a rough prototype on a founder’s workbench.

Working with RhythmRx

From an idea to something an investor can believe.

For early-stage teams who need a device, the evidence behind it, and a credible route to market.

Most medical device startups do not fail on the technology.

They run out of runway between the working prototype and the cleared, manufacturable product. That gap is longer than it looks and it is full of work that is easy to underestimate: design controls, verification evidence, clinical data, transfer documentation, supplier qualification.

We structure that gap into milestones you can fund, so each raise buys a demonstrable step forward.

How we work with early-stage teams

Scoped to the raise you are actually running.

Stage-appropriate scope

We scope to the next milestone, not to a five-year programme you cannot fund yet.

Evidence that raises

Deliverables chosen so technical progress converts into something an investor or partner recognises.

One partner, not five vendors

Engineering, clinical and regulatory in one place, so nothing falls between contracts.

Manufacturing already in place

No search for a manufacturer at the point you can least afford delay.

First conversation

What the first conversation covers.

It is short and specific. We are trying to find the nearest milestone worth funding, not to sell you a programme.

Where the device actually stands today.

The intended use and claims you want to make.

The regulatory pathway that follows from those claims.

The nearest milestone worth funding.

Next step

Building a first device?

Bring the prototype, the pitch deck or just the problem. We will tell you what the next milestone should be.